Inhalable Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “Inhalable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Inhalable Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
An Inhalable Drug Delivery device is meant to administer medications that are to be inhaled deeply into the lungs. Drugs are delivered either by the nasal or oral respiratory route.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Inhalable Drug Delivery under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Inhalable Drug Delivery and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Inhalable Drug Delivery under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Inhalable Drug Delivery Overview
Products under Development
Inhalable Drug Delivery - Pipeline Products by Stage of Development
Table Figure 1: Inhalable Drug Delivery - Pipeline Products by Stage of Development
Table Inhalable Drug Delivery - Pipeline Products by Stage of Development
Inhalable Drug Delivery - Pipeline Products by Segment
Table Figure 2: Inhalable Drug Delivery - Pipeline Products by Segment Pipeline Products by Segment n=104
Table Inhalable Drug Delivery - Pipeline Products by Segment
Inhalable Drug Delivery - Pipeline Products by Territory
Table Figure 3: Inhalable Drug Delivery - Pipeline Products by Territory
Table Inhalable Drug Delivery - Pipeline Products by Territory
Inhalable Drug Delivery - Pipeline Products by Regulatory Path
Table Figure 4: Inhalable Drug Delivery - Pipeline Products by Regulatory Path
Table Inhalable Drug Delivery - Pipeline Products by Regulatory Path
Inhalable Drug Delivery - Pipeline Products by Estimated Approval Date
Table Figure 5: Inhalable Drug Delivery - Pipeline Products by Estimated Approval Date
Table Inhalable Drug Delivery - Pipeline Products by Estimated Approval Date
Inhalable Drug Delivery - Ongoing Clinical Trials
Table Figure 6: Inhalable Drug Delivery - Ongoing Clinical Trials
Table Inhalable Drug Delivery - Ongoing Clinical Trials
Inhalable Drug Delivery - Pipeline Products under Development by Companies
Inhalable Drug Delivery Companies - Pipeline Products by Stage of Development
Table Inhalable Drug Delivery Companies - Pipeline Products by Stage of Development
Inhalable Drug Delivery - Companies Pipeline Products by Stage of Development
Table Inhalable Drug Delivery - Companies Pipeline Products by Stage of Development
Inhalable Drug Delivery Companies and Product Overview
Table INOpulse - A Phase 3 Study to INOpulse for the Treatment of Fibrotic Interstitial Lung Disease
Table INOpulse - A Randomized, Double-Blind, Placebo-Controlled Dose Escalation Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2)
Table INOpulse - An Open-label Long-term Safety Study of Inhaled Nitric Oxide (iNO) for PAH for Subjects in the PULSEPAH- 006 and PULSE-PAH-004 Studies Who Continue to Need iNO Therapy
Table INOpulse - Expanded Access: Pulsed, Inhaled Nitric Oxide (iNO) for the Treatment of Patients With Serious Disease or Conditions Associated With Pulmonary Hypertension
Table INOpulse - INOvation-2 Clinical Study of INOpulse Device
Table INOpulse - Phase IIb Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects in Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease (PH-COPD)
Table INOpulse - Pivotal Phase 3 Study Evaluate the INOpulse for the Treatment of Pulmonary Hypertension Associated with Pulmonary Fibrosis
Table Lung-Targeted BOS Device - A Phase IIa Multi-center, Randomized, Single-blind Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation
Table Lung-Targeted BOS Device - A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Double Lung Transplant
Table Lung-Targeted BOS Device - A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Single Lung Transplant
Table Lung-Targeted BOS Device - A Phase III, Extension Clinical Trial to Demonstrate Efficacy and Safety of Liposomal Cyclosprine A Via the PARI Investigational eFlow Device and SoC in Treating Bronchiolitis Obliterans in Patients Post Single or Double Lung Transplant
Bridgesource Medical Corp Company Overview
Bridgesource Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
Table INP105 - A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Single Dose, 2-Way, 2-Period Crossover Safety and Exploratory Efficacy Study of INP105 (POD-OLZ) for the Acute Treatment of Agitation in Adolescents and Young Adults With Autism Spectrum Disorder
Inhalation Sciences Sweden AB Company Overview
Inhalation Sciences Sweden AB Pipeline Products & Ongoing Clinical Trials Overview
Table Inhalation Sciences Sweden AB Pipeline Products & Ongoing Clinical Trials Overview
Table PreciseInhale System - Product Status
Table PreciseInhale System - Product Description
Table Inhalation Sciences Sweden AB - Ongoing Clinical Trials Overview
Table PreciseInhale System - A Clinical Validation Study of PreciseInhale System in Healthy Volunteers
Table PH94B Neuroactive Nasal Spray - A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Tolerability of the Acute Administration of Fasedienol to Relieve Anxiety Symptoms in Adult Subjects with SAD